Tag: Alexion Pharmaceuticals

Alexion bags Ultomiris EU approval for paroxysmal nocturnal hemoglobinuria

pharmanewsdaily- July 5, 2019

Ultomiris EU approval : Alexion Pharmaceuticals has secured approval from the European Commission (EC) for its C5 complement inhibitor Ultomiris (ravulizumab) for the treatment of ... Read More

Alexion to acquire Boston-based Syntimmune in $1.2bn deal

pharmanewsdaily- September 30, 2018

Alexion acquisition of Syntimmune : US pharma company Alexion Pharmaceuticals has signed a deal of around $1.2 billion to acquire Syntimmune, a Boston-based clinical-stage biotech ... Read More

Alexion to acquire Swedish pharma company Wilson Therapeutics for $855m

pallavi123- April 14, 2018

Pharma acquisition news : US-based Alexion Pharmaceuticals through an all-cash deal of SEK7.1 billion ($855 million) will acquire Wilson Therapeutics, a Swedish pharma company focused ... Read More